Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

pneumococcal conjugate vaccine (PCV13), and pneumococcal polysaccharide vaccine (PPSV23). The PCV13 should be administered first, followed by the PPSV23 after eight weeks. Patients over the age of 60 ...

Although pneumococcal polysaccharide vaccine is a standard preventive intervention — and serves as a "quality indicator" in some settings — controversy over its effectiveness simmers in the ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

Bacterial pneumonia is most commonly caused by a bacteria called Streptococcus pneumoniae which accounts for around 50% of cases. Other common causes include Haemophilus influenzae, Chlamydia ...

Trump’s choice to lead the nation’s health agencies, formally asked the Food and Drug Administration to revoke the authorization of all Covid vaccines during a deadly phase of the pandemic ...

Covid vaccines saved lives. Lots of them. Research by the World Health Organization (WHO) now puts the number at 475,000 in the UK with many more kept out of hospital or off a ventilator.

The CDC recommends one dose of PCV15, PCV20, or PCV21 for people 50 and older who have never received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown. If PCV15 is ...

combined with the 23-valent pneumococcal polysaccharide vaccine (PPSV23). These findings were published in Infectious Diseases and Therapy. After the first PCVs were introduced in 2000, there was a ...

National Glycoengineering Research Center, Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, ...

Two types of pneumococcal vaccine are available. The 23-valent pneumococcal polysaccharide vaccine (PPV23) is used in adults and children >2 years of age. By contrast, pneumococcal conjugate ...